We are aware of an ongoing issue affecting users' ability to access and submit forms, including registration and faculty forms, and evaluations. Our CloudCME support team is working to resolve the issue. We apologize for the inconvenience.
8/31/2026
8/31/2026 11:23:19 AM

2019 Mid-Atlantic Ovarian Cancer Symposium


2019 Mid-Atlantic Ovarian Cancer Symposium Banner

Add to Calendar 2019 Mid-Atlantic Ovarian Cancer Symposium 6/15/2019 12:00:00 AM 6/15/2019 5:00:00 PM America/New_York For More Details: https://medstar.cloud-cme.com/Ovarian Description: Eight steps in the management of ovarian cancer will be addressed by carefully chosen speakers and debaters. Controversial management strategies will be targeted and three debates are planned. These include goals of cytoreduction, use of HIPEC, and use of long-term IP chemotherapy. Use of HIPEC in recurrent disease is also a central focus. After each of the eight topics/debates a series of 5-10 questions will be directed ... Bethesda Marriott false MM/DD/YYYY


Date & Location
Saturday, June 15, 2019, 12:00 AM - 5:00 PM, Bethesda Marriott

Target Audience
Specialties - Gynecologic Oncology, Gynecology, Medical Oncology, Obstetrics, Oncology, Surgery

Overview

Eight steps in the management of ovarian cancer will be addressed by carefully chosen speakers and debaters. Controversial management strategies will be targeted and three debates are planned. These include goals of cytoreduction, use of HIPEC, and use of long-term IP chemotherapy. Use of HIPEC in recurrent disease is also a central focus. After each of the eight topics/debates a series of 5-10 questions will be directed at the audience and their responses recorded.  After the symposium, a clinical pathway will be constructed based on the presentations and audience feedback, and sent to each participant.


Objectives
At the conclusion of this activity, the learner will be able to

  1. Implement selection criteria to determine which patients should receive neoadjuvant chemotherapy
  2. Compare surgical strategies for complete and partial cytoreductions
  3. Identify proper utilization of minimally invasive techniques in cytoreductive surgery
  4. Define the role of HIPEC in primary or interval cytoreduction
  5. Implement selection criteria to determine which patients, if any, should be treated by IP adjuvant chemotherapy
  6. Define the role of HIPEC with recurrent diseases

Registration

Physician

$100

Resident or Fellow

$75

Physician Assistant

$50

Nurse Practitioner

$50

Nurse

$50

Medical Student

 $0

Allied Health

$50


Accreditation

Accreditation
In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC) and the American Academy of PAs (AAPA) to provide continuing education for the healthcare team.

Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 8 Interprofessional Continuing Education (IPCE) credits for learning and change.


Credits
AMA PRA Category 1 Credits™ Physician (8.00 hours), Interprofessional Continuing Education (8.00 hours), Non-Physician Member of the Healthcare Team (8.00 hours), Nurse - ANCC (8.00 hours)